SCHEMBL15066091

SCHEMBL15066091

CC(O)[CH]c1cccc(Cl)c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ PPP1R15A O75807 1/20 0.43
▸ MELK Q14680 1/20 0.43
▸ PPP1R15B Q5SWA1 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ CYP1A2 P05177 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ PNMT P11086 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ LMNA P02545 3/20 0.41
▸ GLA P06280 1/20 0.41
▸ TSHR P16473 2/20 0.40
▸ PTGS2 P35354 1/20 0.39
▸ DRD2 P14416 2/20 0.37
▸ DRD3 P35462 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL253550 1.00 SMN1; SMN2 (0.50) SMN1; SMN2L3MBTL1PPP1R15AMELKPPP1R15B
SCHEMBL16054198 0.83 ALDH1A1 (0.52) SMN1; SMN2CYP1A2ALDH1A1LMNATSHR
SCHEMBL15066406 0.83 ALDH1A1 (0.52) SMN1; SMN2CYP1A2ALDH1A1LMNATSHR
SCHEMBL15066569 0.83 ALDH1A1 (0.52) SMN1; SMN2CYP1A2ALDH1A1LMNATSHR
SCHEMBL16055929 0.77 ALDH1A1 (0.44) SMN1; SMN2NPSR1CYP1A2CYP3A4CYP2D6
SCHEMBL16951865 0.76 SMN1; SMN2 (0.47) SMN1; SMN2L3MBTL1PPP1R15AMELKPPP1R15B
SCHEMBL13104870 0.72 SMN1; SMN2 (0.43) SMN1; SMN2L3MBTL1PPP1R15AMELKPPP1R15B
SCHEMBL1547373 0.72 L3MBTL1 (0.46) SMN1; SMN2L3MBTL1PPP1R15AMELKPPP1R15B
SCHEMBL40188 0.72 ALDH1A1 (0.65) SMN1; SMN2L3MBTL1PPP1R15AMELKPPP1R15B
SCHEMBL16951940 0.72 L3MBTL1 (0.50) SMN1; SMN2L3MBTL1PPP1R15AMELKPPP1R15B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968212-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME Bio-Pharm Solutions Co., Ltd. (KR) 2016-01-20 — — EP claimed
EP-2797878-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE Bio-Pharm Solutions Co., Ltd. (KR) 2014-11-05 — — EP claimed
EP-2797879-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN ALLEVIATING OR TREATING PAIN AND NEUROPATHIC PAIN Bio-Pharm Solutions Co., Ltd. (KR) 2014-11-05 — — EP claimed
EP-2797877-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING MULTIPLE SCLEROSIS Bio-Pharm Solutions Co., Ltd. (KR) 2014-11-05 — — EP claimed
WO-2014142520-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2014-09-18 — — WO claimed
WO-2013100569-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING MULTIPLE SCLEROSIS BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-07-04 — — WO claimed
WO-2013100567-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN ALLEVIATING OR TREATING PAIN AND NEUROPATHIC PAIN BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-07-04 — — WO claimed
WO-2013100568-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-07-04 — — WO claimed
EP-2968212-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME Bio-Pharm Solutions Co., Ltd. (KR) 2016-01-20 — — EP disclosed
EP-2797876-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING ALS Bio-Pharm Solutions Co., Ltd. (KR) 2014-11-05 — — EP disclosed
WO-2014142520-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2014-09-18 — — WO disclosed
WO-2013100571-A9 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING ALS BIO-PHARM SOLUTIONS CO., LTD. (KR) 2014-09-18 — — WO disclosed
WO-2013100571-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING ALS BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-07-04 — — WO disclosed
Send feedback